๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study

โœ Scribed by Bacci, Gaetano; Gherlinzoni, Franco; Picci, Piero; Van Horn, James R.; Jaffe, Norman; Guerra, Aristide; Ruggieri, Pietro; Biagini, Roberto; Capanna, Rodolfo; Toni, Aldo; Mercuri, Mario; Dallari, Dante; Campanacci, Mario


Book ID
120248577
Publisher
Elsevier Science
Year
1986
Weight
843 KB
Volume
22
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A randomized study comparing high-dose m
โœ Krailo, M. ;Ertel, I. ;Makley, J. ;Fryer, C. J. H. ;Baum, E. ;Weetman, R. ;Yunis ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 591 KB

Methotrexate (MTX) has demonstrated significant activity against relapsed and metastatic osteosarcoma. However, there is little published data to indicate the appropriate dose for MTX when given as a component of a multidrug regimen for the treatment of osteosarcoma. Therefore, the investigators at

Adjuvant six cycles of high-dose adriamy
โœ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl